Anything is possible with this stock/company because it is tied into many global issues and national headlines, in terms of disease, plant-based tech, and a modest pipeline to boot. It is also a price acquisition candidate.
They also have an amazing pipeline of patents and intellectual property, and intellectual property is KING globally, because when the patents/tech is needed/used, all trains have to go through IBIO.